Health Canada issues draft guidelines on follow-on biologics

03/24/2008 | FDAnews

Health Canada has issued preliminary guidance for companies seeking approval for "subsequent-entry biologics," the government's first step toward allowing the sale of follow-on versions of biotech drugs. The agency, which plans to publish more guidelines for specific biologic product classes, says existing laws authorize it to clear subsequent-entry products until legislation creates a new approval path.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ